ERGOMED opens new facility in Russia

29 October 2007

Frankfurt, Germany-based ERGOMED Group, a specialized international clinical development company, has opened a new facility in Russia. At the same time, the firm is appointing Sergei Drapkin - who was a co-found of Quintiles Transnational's Moscow branch - as the managing director for the Russian office.

The new office, which strengthens ERGOMED's position in Eastern Europe and Central Asia, will support ongoing operations in Russia, Ukraine, Kazakhstan and Belorussia. These countries represent emerging regions with very significant potential for high patient recruitment. Clinical research in the German firm's areas of specialization in these regions is also of a high quality, given the generally high standard of medical training and the concentration of medical expertise in a few centers, it claims.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight